BRANDON BODIE: Open Payments
NPI 1912401258 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 41 payments from 15 companies in 2025. Trend: 2023 $2,113 · 2024 $1,814 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $143 |
| Novo Nordisk Inc | 9 | $139 |
| SHIELD THERAPEUTICS INC | 4 | $82 |
| Phathom Pharmaceuticals, Inc. | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| ABBVIE INC. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Daiichi Sankyo Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: Wegovy, ACCRUFER, VOQUEZNA, FARXIGA, LEQVIO, AIRSUPRA, Veozah, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
